Francisco J. Leyva

628 total citations
20 papers, 425 citations indexed

About

Francisco J. Leyva is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Francisco J. Leyva has authored 20 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Francisco J. Leyva's work include HIV Research and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Francisco J. Leyva is often cited by papers focused on HIV Research and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Francisco J. Leyva collaborates with scholars based in United States, Costa Rica and Israel. Francisco J. Leyva's co-authors include Armando Huaringa, Jaime Signes‐Costa, Joshua J. Anzinger, Sergio Giralt, Richard E. Champlin, Howard S. Kruth, R. Champlin, Rodolfo C. Morice, Issam Raad and Ammar Darwish and has published in prestigious journals such as The Journal of Immunology, Annals of the New York Academy of Sciences and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Francisco J. Leyva

16 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco J. Leyva United States 10 143 140 98 83 65 20 425
Vikas Kohli India 13 110 0.8× 70 0.5× 231 2.4× 60 0.7× 41 0.6× 50 629
Alex Ganetsky United States 13 109 0.8× 49 0.3× 163 1.7× 177 2.1× 114 1.8× 35 504
Øystein Wendelbo Norway 12 123 0.9× 32 0.2× 52 0.5× 93 1.1× 70 1.1× 37 409
Karim Boudjedir France 8 84 0.6× 50 0.4× 61 0.6× 53 0.6× 61 0.9× 23 505
F. Athanassiadou Greece 10 83 0.6× 41 0.3× 64 0.7× 126 1.5× 37 0.6× 20 349
Keith Sultan United States 12 117 0.8× 81 0.6× 170 1.7× 68 0.8× 46 0.7× 52 527
Fin Breatnach Ireland 13 90 0.6× 46 0.3× 122 1.2× 127 1.5× 92 1.4× 26 571
Vedat Uygun Türkiye 13 85 0.6× 72 0.5× 48 0.5× 79 1.0× 32 0.5× 57 486
José Luis Pico France 7 72 0.5× 59 0.4× 30 0.3× 117 1.4× 111 1.7× 7 388
Hilde Vanpoucke Belgium 10 193 1.3× 76 0.5× 72 0.7× 19 0.2× 59 0.9× 13 393

Countries citing papers authored by Francisco J. Leyva

Since Specialization
Citations

This map shows the geographic impact of Francisco J. Leyva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco J. Leyva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco J. Leyva more than expected).

Fields of papers citing papers by Francisco J. Leyva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco J. Leyva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco J. Leyva. The network helps show where Francisco J. Leyva may publish in the future.

Co-authorship network of co-authors of Francisco J. Leyva

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco J. Leyva. A scholar is included among the top collaborators of Francisco J. Leyva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco J. Leyva. Francisco J. Leyva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gracia, Paulino Vigil‐De, et al.. (2020). Mortalidad materna en gestantes SARSCoV- 2 anticuerpos IgM/IgG positivos asociada a preeclampsia severa, eclampsia y síndrome HELLP. Reporte de 3 casos. Revista Peruana de Ginecología y Obstetricia. 66(3). 1 indexed citations
2.
Gracia, Paulino Vigil‐De, et al.. (2020). Maternal mortality in pregnant women with positive SARS-CoV-2 antibodies and severe preeclampsia. Report of 3 cases. 66(3). 6.
3.
Gracia, Paulino Vigil‐De, et al.. (2020). Características clínicas de gestantes en trabajo de parto con infección SARSCoV- 2 en la altura: serie de casos. Revista Peruana de Ginecología y Obstetricia. 66(3).
4.
Leyva, Francisco J., Edward J. Fuchs, Rahul P. Bakshi, et al.. (2015). Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates. AIDS Research and Human Retroviruses. 31(11). 1089–1097. 10 indexed citations
5.
Leyva, Francisco J., et al.. (2013). Association Among Obstructive Sleep Apnea Risk and Blood Chemistry Changes in the U.S. Population: National Health and Nutrition Examination Survey 2005 – 2008. 11(2). 2 indexed citations
6.
Leyva, Francisco J., Rahul P. Bakshi, Edward J. Fuchs, et al.. (2013). Isoosmolar Enemas Demonstrate Preferential Gastrointestinal Distribution, Safety, and Acceptability Compared with Hyperosmolar and Hypoosmolar Enemas as a Potential Delivery Vehicle for Rectal Microbicides. AIDS Research and Human Retroviruses. 29(11). 1487–1495. 40 indexed citations
7.
Huaringa, Armando, et al.. (2012). The Weaning Index as Predictor of Weaning Success. Journal of Intensive Care Medicine. 28(6). 369–374. 19 indexed citations
8.
Leyva, Francisco J., Joshua J. Anzinger, J. Philip McCoy, & Howard S. Kruth. (2011). Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors. BMC Biotechnology. 11(1). 13–13. 15 indexed citations
9.
Ong, Daniel, et al.. (2010). Extracellular cholesterol-rich microdomains generated by human macrophages and their potential function in reverse cholesterol transport. Journal of Lipid Research. 51(8). 2303–2313. 29 indexed citations
10.
Leyva, Francisco J. & Kevan Roberts. (2010). Crocidolite Induces Prostaglandin I2 Release Mediated by Vitronectin Receptor and Cyclooxygenase-2 in Lung Cells. Lung. 188(2). 133–141. 2 indexed citations
11.
Huaringa, Armando, et al.. (2010). The lung permeability index: A feasible measurement of pulmonary capillary permeability. Respiratory Medicine. 105(2). 230–235. 6 indexed citations
12.
Anzinger, Joshua J., Janet Chang, Qing Xu, et al.. (2010). Native Low-Density Lipoprotein Uptake by Macrophage Colony-Stimulating Factor–Differentiated Human Macrophages Is Mediated by Macropinocytosis and Micropinocytosis. Arteriosclerosis Thrombosis and Vascular Biology. 30(10). 2022–2031. 54 indexed citations
13.
Anzinger, Joshua J., Janet Chang, Qing Xu, et al.. (2010). Native low-density lipoprotein uptake by Macrophage Colony-Stimulating Factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis (134.12). The Journal of Immunology. 184(Supplement_1). 134.12–134.12. 2 indexed citations
14.
Leyva, Francisco J., Mark A. Pershouse, & Andrij Holian. (2009). Modified low density lipoproteins binding requires a lysine cluster region in the murine macrophage scavenger receptor class A type II. Molecular Biology Reports. 37(6). 2847–2852. 4 indexed citations
15.
16.
Leyva, Francisco J.. (2007). The role of silicates in interstitial lung disease. The Mathematics Enthusiast.
17.
Pfau, Jean C., et al.. (2004). Environmental oxygen tension affects phenotype in cultured bone marrow-derived macrophages. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(2). L354–L362. 25 indexed citations
18.
Huaringa, Armando, Francisco J. Leyva, Jaime Signes‐Costa, et al.. (2000). Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplantation. 25(9). 975–979. 66 indexed citations
19.
Huaringa, Armando, et al.. (2000). Outcome of bone marrow transplantation patients requiring mechanical ventilation. Critical Care Medicine. 28(4). 1014–1017. 108 indexed citations
20.
Verschraegen, Claire F., Brian E. Gilbert, Armando Huaringa, et al.. (2000). Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9‐Nitro‐20(S)‐Camptothecin in Patients with Advanced Malignancies in the Lungs. Annals of the New York Academy of Sciences. 922(1). 352–354. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vikas Kohli Breakdown of academic impact, for papers by Alex Ganetsky Breakdown of academic impact, for papers by Øystein Wendelbo Breakdown of academic impact, for papers by Karim Boudjedir Breakdown of academic impact, for papers by F. Athanassiadou Breakdown of academic impact, for papers by Keith Sultan Breakdown of academic impact, for papers by Fin Breatnach Breakdown of academic impact, for papers by Vedat Uygun Breakdown of academic impact, for papers by José Luis Pico Breakdown of academic impact, for papers by Hilde Vanpoucke
Rankless by CCL
2026